These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 28121231)
1. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects. Shi N; Zhang Y; Zheng H; Zhu Z; Wang D; Li S; Li Y; Yang L; Zhang J; Bai Y; Lu Q; Zhang Z; Luo F; Yu C; Li L Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28121231 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study. Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350 [TBL] [Abstract][Full Text] [Related]
3. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above. Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585 [TBL] [Abstract][Full Text] [Related]
5. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen). Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792 [TBL] [Abstract][Full Text] [Related]
6. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hu Q; Liu MQ; Zhu ZG; Zhu ZR; Lu S Hum Vaccin Immunother; 2014; 10(6):1645-9. PubMed ID: 24632727 [TBL] [Abstract][Full Text] [Related]
7. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China. Li R; Huang L; Li J; Mo Z; He B; Wang Y; Wu X; Minutello M; Guinet-Morlot F; Pichon S Vaccine; 2013 Dec; 31(50):5940-7. PubMed ID: 24148575 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial. Shen H; Wang Z; Yang B; Cai K; Jiang C; Xie R; Xiao H; Ren Q; Qi Z; Li J; Li Q; Ye J; Zhan F Hum Vaccin Immunother; 2021 Feb; 17(2):351-357. PubMed ID: 32783769 [No Abstract] [Full Text] [Related]
9. Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China. Hou Q; Liu S; Liu C; Wang X; Shi J; Chen Q; Lv X; Zhu Z; Wang C; Yin W Travel Med Infect Dis; 2024; 60():102735. PubMed ID: 38992484 [TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial. Zhang L; Huang S; Cai L; Zhu Z; Chen J; Lu S; Zhu Z; Zhang M; Fang Y; Hu Q Hum Vaccin Immunother; 2021 Aug; 17(8):2547-2553. PubMed ID: 33631078 [TBL] [Abstract][Full Text] [Related]
11. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382 [TBL] [Abstract][Full Text] [Related]
12. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults. Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228 [TBL] [Abstract][Full Text] [Related]
13. Rabies Prophylaxis Strategy in Iran, a Need for an Alternative Strategy: Would the Essen Regimen be Replaced by Zagreb Protocol? Rahimi P; Vahabpour R; Shirzadi MR; Bahramali G; Aghasadeghi MR Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775880 [TBL] [Abstract][Full Text] [Related]
14. Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups. Fang Y; Chen L; Liu MQ; Zhu ZG; Zhu ZR; Hu Q PLoS Negl Trop Dis; 2014 Dec; 8(12):e3412. PubMed ID: 25522244 [TBL] [Abstract][Full Text] [Related]
15. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Liu H; Huang G; Tang Q; Li J; Cao S; Fu C; Cao Q; Liu B; Pan H; Wang M Hum Vaccin; 2011 Feb; 7(2):220-4. PubMed ID: 21311216 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis. Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals: A randomized, parallel-controlled of homologous vaccine with different immune procedure study. Li L; Xu J; Zhang J; Wang F; Cai J; Yang L; Zhu Z; Bai Y; Jia B; Ma J; Shi N; Li S Hum Vaccin Immunother; 2024 Dec; 20(1):2403177. PubMed ID: 39358206 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India. Ashwath Narayana DH; Madhusudana SN; Sampath G; Tripathy RM; Sudarshan MK; Gangaboraiah ; Ravish HS; Satapathy DM; Gowda G; Holla R; Ashwin BY; Padhi A; Manjula S; Patel PM Hum Vaccin Immunother; 2014; 10(1):120-5. PubMed ID: 24030586 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446 [TBL] [Abstract][Full Text] [Related]
20. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]